Stockscreener 앱 받기
47.15
0.38%
0.18
시간 외 거래:
47.15
Rigel Pharmaceuticals 주식(RIGL)의 최신 뉴스
Rigel Secures Credit Facility for Up to $60 Million - Lelezard
Rigel (RIGL) Drops -1.36% — Key Support at $46.26 2026-09-29Wave Equality - siam.in
RIGL Stock Jumps 15%, Short Interest Surges To Record High – Why Is Retail Eyeing A Further 40% Upside? - Stocktwits
Arvinas Announces First Patient Dosed in Phase 1/2 Clinical Trial of ARV-6723, the Company’s First Immuno-Oncology Candidate - GlobeNewswire Inc.
Precision Trading with Rigel Pharmaceuticals Inc. (RIGL) Risk Zones - Stock Traders Daily
Rigel Pharmaceuticals, Inc. (RIGL) Options ChainYahoo Finance - Yahoo! Finance Canada
Rigel Pharmaceuticals, Inc. (RIGL) Presents at H.C. Wainwright 28th Annual Global Investment ConferenceSlideshow (NASDAQ:RIGL) 2026-09-15 - Seeking Alpha
Rigel Pharmaceuticals at H.C. Wainwright conference: growth plan broadens - Investing.com
Rigel Pharmaceuticals at H.C. Wainwright conference: growth plan broadens By Investing.com - Investing.com Australia
Rigel Pharmaceuticals, Inc. (RIGL) Presents at 12th Annual Cantor Fitzgerald Global Healthcare ConferenceSlideshow (NASDAQ:RIGL) 2026-09-15 - Seeking Alpha
Rigel Pharmaceuticals at Cantor conference: veppanu launch leads growth push - Investing.com Nigeria
Rigel Pharmaceuticals at Cantor conference: veppanu launch leads growth push By Investing.com - Investing.com South Africa
Rigel Pharmaceuticals (RIGL) Institutional Ownership 2026 $RIGL - MarketBeat
H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $85 - Moomoo
Trading the Move, Not the Narrative: (RIGL) Edition - Stock Traders Daily
EVP & Chief Financial Officer At Rigel Pharmaceuticals Exercises Options Worth $123K - Benzinga
Rigel (NASDAQ: RIGL) CCO now holds 61,622 shares - Stock Titan
Rigel Pharmaceuticals (RIGL) CEO returns 2,424 shares to issuer - Stock Titan
Rigel Pharmaceuticals (NASDAQ: RIGL) insider now holds 50,559 shares - Stock Titan
Rigel Pharmaceuticals CFO to present at three m... - Pluang
Rigel to Participate in Upcoming September Investor Conferences - PR Newswire
Rigel Pharmaceuticals (RIGL) CFO exercises options and uses shares to cover taxes - Stock Titan
Rigel Pharmaceuticals Inc. (RIGL) Peer Comparison – Compare with Others - Value Research
Rigel Pharmaceuticals Inc. (RIGL) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Rigel (RIGL) Results Breakdown: EPS Exceeds Its Estimate for the Current Session; Market Reaction: Shares Finish 3.64% Down in Latest TradingSurprise Factor Analysis - Vinanet
Rigel Pharmaceuticals (NASDAQ:RIGL) Rating Increased to Hold at Zacks Research - MarketBeat
HC Wainwright Analysts Increase Earnings Estimates for RIGL - MarketBeat
Rigel Pharmaceuticals Inc (RIGL) (Q2 2026) Earnings Call Highlig - GuruFocus
Piper Sandler Maintains Rigel Pharmaceuticals(RIGL.US) With Hold Rating, Raises Target Price to $49 - Moomoo
RIGL Maintains Neutral Rating -- Price Target Raised to $49.00 b - GuruFocus
RIGL Q2 2026 Earnings: EPS Surges Past Estimates with 39% Upside SurpriseEstimate Revision Count - careplusvn.com
Rigel Pharmaceuticals (RIGL) Stock Sees Fair Value Lift As Veppanu Launch Adds Growth Hope - Yahoo Finance
Rigel Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript - GuruFocus
(RIGL) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
RIGL Maintained by HC Wainwright & Co. -- Price Target Raised to $85 - GuruFocus
Armistice Capital (RIGL) reports 1.67M Rigel Pharmaceuticals shares in 13G/A - Stock Titan
Rigel announces availability of Veppanu in the USA - The Pharma Letter
Rigel Says Breast Cancer Drug Veppanu Now Available in US, Puerto Rico - marketscreener.com
Rigel Pharmaceuticals (RIGL): Soleus Capital group discloses 9.9% ownership stake - Stock Titan
Rigel's VEPPANU Is Now Available for Certain Advanced Breast Cancers - Stock Titan
Rigel Pharmaceuticals, Inc. (RIGL) Latest Stock News & Headlines - finance.yahoo.com
Rigel (RIGL) Q2 2026 Earnings Call Transcript - The Globe and Mail
Rigel Pharmaceuticals (RIGL) Short Interest & Short Float | Updated Aug 2026 $RIGL - MarketBeat
Rigel Pharmaceuticals, Inc. $RIGL Shares Purchased by Dimensional Fund Advisors LP - MarketBeat
Rigel Pharmaceuticals (RIGL) Advances 3.71% to $41.66 as Bullish Momentum Targets $43.74 ResistanceBollinger Band - dars.gov.et
Janus Henderson Group PLC Boosts Position in Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat
Rigel Pharmaceuticals Inc (RIGL) Stock News Today - TradingKey
Rigel Pharmaceuticals Inc (RIGL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
HC Wainwright Issues Pessimistic Estimate for RIGL Earnings - MarketBeat
Pacer Advisors Inc. Purchases 48,882 Shares of Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat
Cantor Fitzgerald Maintains Rigel Pharmaceuticals(RIGL.US) With Hold Rating, Raises Target Price to $43 - 富途牛牛
HC Wainwright Issues Pessimistic Forecast for RIGL Earnings - MarketBeat
Empowered Funds LLC Takes Position in Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat
Rigel Pharmaceuticals (RIGL) Stock Rally Runs Into Earnings Quality Doubts - simplywall.st
Rigel Pharmaceuticals in-licenses Veppanu, targ... - Pluang
Rigel Pharmaceuticals: A Four-Drug Company With A Clinical Catalyst Ahead (NASDAQ:RIGL) - Seeking Alpha
0.05%
0.82%
자본화:
|
볼륨(24시간):